Document
Academic Article
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers
Generically Dependent Continuant
RDF description of A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers - http://irises.unibs.it/resource/item/82044
Article
Information Content Entity